免疫疗法:乳腺癌治疗的建设性方法
Umer Anayyat1, Faiza Ahad1, Tobias Achu Muluh1
1Department of Physiology, School of Basic Medical Sciences, Health Sciences Center, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong, 518055, People's Republic of China.
本综述探讨了乳腺癌的免疫疗法,包括免疫检查点阻断剂 (ICB) 和癌症疫苗. 它强调了诸如瘤耐药性等挑战,并讨论了克服这些挑战的策略,重点关注癌症干细胞.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 免疫检查点阻塞 (ICB) 已经改变了乳腺癌治疗,特别是三阴性乳腺癌 (TNBC).
- 尽管PD-1/PD-L1抑制剂的初步积极发现,瘤复发和耐药性仍然是重大挑战.
- 癌症干细胞 (CSCs) 在瘤发育和生长中起着至关重要的作用,是克服抗性的目标.
研究的目的:
- 审查乳腺癌目前的免疫治疗选择.
- 探索抗 ICB 的分子机制以及克服它们的先进策略.
- 检查癌症干细胞抗原,标记物和癌症疫苗在乳腺癌治疗中的作用.
主要方法:
- 对乳腺癌中现有的免疫疗法,ICB和CSC的文献综述.
- 对ICBs耐药性的基础分子机制的分析.
- 综合有关癌症干细胞抗原,标记物和疫苗开发的信息.
主要成果:
- 由于耐药性,ICB在TNBC患者的一个子组中显示出有希望但有效性有限.
- 了解CSC及其抗原为提高免疫疗法的有效性提供了潜在的策略.
- 目前正在开发各种针对瘤抗原的癌症疫苗,以诱导活性免疫.
结论:
- 克服ICB抵抗对于改善乳腺癌治疗结果至关重要.
- 针对CSC和开发有效的癌症疫苗是未来乳腺癌免疫疗法的有希望的途径.
- 对抗性机制的进一步研究和临床试验对于推进乳腺癌免疫疗法至关重要.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
相关概念视频
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
